Search

Search Results
Results 7871 - 7880 of 8357 for allergy
  • Merck announces global sales of $27.4 billion for full-year 2009
    News - 16 Feb 2010
    Merck & Co., Inc. today announced financial results for the fourth quarter and the full year of 2009 which include the results of legacy Schering-Plough operations from the close of the merger on Nov....
  • Nolvadex
    Drug - 9 Sep 2024
    Consumer Medicine Information (CMI) about Nolvadex (Tamoxifen citrate) intended for persons living in Australia.
  • Remifentanil Viatris
    Drug - 19 Aug 2024
    Consumer Medicine Information (CMI) about Remifentanil Viatris (remifentanil) intended for persons living in Australia.
  • Alphamox
    Drug - 12 Aug 2024
    Consumer Medicine Information (CMI) about Alphamox (amoxicillin) intended for persons living in Australia.
  • Arianna 1
    Drug - 7 Aug 2024
    Consumer Medicine Information (CMI) about Arianna 1 (anastrozole) intended for persons living in Australia.
  • Hypnodorm
    Drug - 15 Apr 2024
    Consumer Medicine Information (CMI) about Hypnodorm (flunitrazepam) intended for persons living in Australia.
  • Bosentan Viatris
    Drug - 3 Apr 2024
    Consumer Medicine Information (CMI) about Bosentan Viatris (bosentan) intended for persons living in Australia.
  • Tracleer
    Drug - 30 Jan 2024
    Consumer Medicine Information (CMI) about Tracleer (Bosentan 62.5 mg/125 mg film-coated tablets) intended for persons living in Australia.
  • Lonquex
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Lonquex (Lipegfilgrastim) intended for persons living in Australia.
  • Patanol
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Patanol (Olopatadine hydrochloride) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback